Literature DB >> 7811045

Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.

J S Knapp1, J A Washington, L J Doyle, S W Neal, M C Parekh, R J Rice.   

Abstract

Twenty-five isolates of beta-lactamase-negative strains of Neisseria gonorrhoeae exhibiting decreased susceptibilities to ciprofloxacin (MIC, > or = 0.125 microgram/ml) were isolated from men with uncomplicated gonococcal urethritis in Cleveland, Ohio, from January 1992 through June 1993. The strains belonged to three auxotype-serovar classes: Pro-IB-1 (2 isolates), Pro-IB-2 (21 isolates), and Pro-IB-3 (2 isolates). MICs for strains were in the intermediate or resistant categories for penicillin, the intermediate or susceptible categories for tetracycline (with the exception of one strain that had acquired the 25.2-MDa TetM-containing plasmid) and cefoxitin, and the susceptible categories for ceftriaxone and cefixime (MICs, < or = 0.25 microgram/ml) and spectinomycin (MIC, < or = 256 micrograms/ml). MICs for strains were also in the susceptible category for ofloxacin (MIC, 0.25 microgram/ml) and in categories higher than susceptible for ciprofloxacin (MICs, 0.125 to 0.25 microgram/ml) and ofloxacin (MIC, 0.5 microgram/ml). The diameters of zones of inhibition for these strains ranged from 31 to 39 mm for ciprofloxacin to 28 to 35 mm for ofloxacin. The persistence of these strains over an 18-month period supports the need for routine sentinel surveillance and monitoring of gonococcal isolates, particularly posttreatment isolates, for resistance to quinolones when these agents are used for the primary therapy of uncomplicated gonorrhea.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811045      PMCID: PMC284710          DOI: 10.1128/AAC.38.9.2194

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia.

Authors:  S D Putnam; B S Lavin; J R Stone; E C Oldfield; D G Hooper
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  W R Gransden; C A Warren; I Phillips; M Hodges; D Barlow
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

3.  National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.

Authors:  S K Schwarcz; J M Zenilman; D Schnell; J S Knapp; E W Hook; S Thompson; F N Judson; K K Holmes
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

4.  Rapid method for auxotyping multiple strains of Neisseria gonorrhoeae.

Authors:  H B Short; V B Ploscowe; J A Weiss; F E Young
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

5.  Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males.

Authors:  A H van der Willigen; J C van der Hoek; J H Wagenvoort; H J van Vliet; B van Klingeren; W O Schalla; J S Knapp; T van Joost; M F Michel; E Stolz
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I.

Authors:  J S Knapp; M R Tam; R C Nowinski; K K Holmes; E G Sandström
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

7.  Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  P C Fuchs; A L Barry; C Baker; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

Review 8.  Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States.

Authors:  W L Whittington; J S Knapp
Journal:  Sex Transm Dis       Date:  1988 Oct-Dec       Impact factor: 2.830

9.  Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypes.

Authors:  R J Rice; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

10.  Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand.

Authors:  T E Clendennen; P Echeverria; S Saengeur; E S Kees; J W Boslego; F S Wignall
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

View more
  18 in total

1.  Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999.

Authors:  A Mavroidi; L S Tzouvelekis; P T Tassios; A Flemetakis; M Daniilidou; E Tzelepi
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Continuous surveillance of antibiotic resistant Neisseria gonorrhoeae: A tool to forewarn emerging trends in resistance.

Authors:  K H Yeung
Journal:  Can J Infect Dis       Date:  1995-11

3.  Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.

Authors:  M J van de Laar; Y T van Duynhoven; M Dessens; M van Santen; B van Klingeren
Journal:  Genitourin Med       Date:  1997-12

4.  In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.

Authors:  J S Knapp; S W Neal; M C Parekh; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

5.  Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines.

Authors:  S O Hjelmevoll; D Golparian; L Dedi; D H Skutlaberg; E Haarr; A Christensen; S Jørgensen; Ø J Nilsen; M Unemo; V Skogen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

6.  Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group.

Authors:  M Tanaka; T Matsumoto; M Sakumoto; K Takahashi; T Saika; I Kabayashi; J Kumazawa
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

7.  The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds.

Authors:  Corinne Rouquette-Loughlin; Steven A Dunham; Michael Kuhn; Jacqueline T Balthazar; William M Shafer
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

Review 8.  Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.

Authors:  S V Onrust; H M Lamb; J A Balfour
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

9.  Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

Authors:  C A Ison; P J Woodford; H Madders; E Claydon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.

Authors:  J S Knapp; J A Hale; S W Neal; K Wintersheid; R J Rice; W L Whittington
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.